This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buermeyer, A B Articles by Farnham, P J Search for Related Content PubMed PubMed Citation Articles by Buermeyer, A B Articles by Farnham, P J

The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II.

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.

ABSTRACT

We examined the ability of purified RNA polymerase (RNAP) II lacking the carboxy-terminal heptapeptide repeat domain (CTD), called RNAP IIB, to transcribe a variety of promoters in HeLa extracts in which endogenous RNAP II activity was inhibited with anti-CTD monoclonal antibodies. Not all promoters were efficiently transcribed by RNAP IIB, and transcription did not correlate with the in vitro strength of the promoter or with the presence of a consensus TATA box. This was best illustrated by the GC-rich, non-TATA box promoters of the bidirectional dihydrofolate reductase (DHFR)-REP-encoding locus. Whereas the REP promoter was transcribed by RNAP IIB, the DHFR promoter remained inactive after addition of RNAP IIB to the antibody-inhibited reactions. However, both promoters were efficiently transcribed when purified RNAP with an intact CTD was added. We analyzed a series of promoter deletions to identify which cis elements determine the requirement for the CTD of RNAP II. All of the promoter deletions of both DHFR and REP retained the characteristics of their respective full-length promoters, suggesting that the information necessary to specify the requirement for the CTD is contained within approximately 65 bp near the initiation site. Furthermore, a synthetic minimal promoter of DHFR, consisting of a single binding site for Sp1 and a binding site for the HIP1 initiator cloned into a bacterial vector sequence, required RNAP II with an intact CTD for activity in vitro. Since the synthetic minimal promoter of DHFR and the smallest REP promoter deletion are both activated by Sp1, the differential response in this assay does not result from upstream activators. However, the sequences around the start sites of DHFR and REP are not similar and our data suggest that they bind different proteins. Therefore, we propose that specific initiator elements are important for determination of the requirement of some promoters for the CTD.

This article has been cited by other articles:

• Nair, D., Kim, Y., Myers, L. C. (2005). Mediator and TFIIH Govern Carboxyl-terminal Domain-dependent Transcription in Yeast Extracts. J. Biol. Chem. 280: 33739-33748 [Abstract] [Full Text]  
• Prelich, G. (2002). RNA Polymerase II Carboxy-Terminal Domain Kinases: Emerging Clues to Their Function. Eukaryot Cell 1: 153-162 [Full Text]  
• Garber, M. E., Mayall, T. P., Suess, E. M., Meisenhelder, J., Thompson, N. E., Jones, K. A. (2000). CDK9 Autophosphorylation Regulates High-Affinity Binding of the Human Immunodeficiency Virus Type 1 Tat-P-TEFb Complex to TAR RNA. Mol. Cell. Biol. 20: 6958-6969 [Abstract] [Full Text]  
• Kim, M. K., Nikodem, V. M. (1999). hnRNP U Inhibits Carboxy-Terminal Domain Phosphorylation by TFIIH and Represses RNA Polymerase II Elongation. Mol. Cell. Biol. 19: 6833-6844 [Abstract] [Full Text]  
• McNeil, J. B., Agah, H., Bentley, D. (1998). Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast. Genes Dev. 12: 2510-2521 [Abstract] [Full Text]  
• Long, J. J., Leresche, A., Kriwacki, R. W., Gottesfeld, J. M. (1998). Repression of TFIIH Transcriptional Activity and TFIIH-Associated cdk7 Kinase Activity at Mitosis. Mol. Cell. Biol. 18: 1467-1476 [Abstract] [Full Text]  
• Wada, T., Takagi, T., Yamaguchi, Y., Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Yano, K., Hartzog, G. A., Winston, F., Buratowski, S., Handa, H. (1998). DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12: 343-356 [Abstract] [Full Text]  
• Orphanides, G, Lagrange, T, Reinberg, D (1996). The general transcription factors of RNA polymerase II.. Genes Dev. 10: 2657-2683  
• Buermeyer, A. B., Strasheim, L. A., McMahon, S. L., Farnham, P. J. (1995). Identification of cis-Acting Elements That Can Obviate a Requirement for the C-terminal Domain of RNA Polymerase II. J. Biol. Chem. 270: 6798-6807 [Abstract] [Full Text]  
• Weeks, J R, Hardin, S E, Shen, J, Lee, J M, Greenleaf, A L (1993). Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing.. Genes Dev. 7: 2329-2344 [Abstract]